Please follow my twitter account @jsm2334 for more recent commentaries and threads on COVID-19 topics

Covid-19 Data Science
Finding the signal in the noise of Covid-19
Reporting and balanced evaluation of research results, data sets, applications and models, and commentaries related to Covid-19 and its underlying virus, SARS-Cov-2

Vaccine insights from English population-wide COVID/non-COVID deaths split by vaccination status/age
Summary of Key points: The UK ONS posted data on all COVID-19 and non-COVID-19 deaths in England from Jan1 through Oct31, 2021, split out...

Interview on Surani Fernando's "Vax Files" Apple podcast, "Real World Effectiveness of the Vaccine"
I was interviewed by investigative journalist Surani Fernando for her podcast here in the episode on "Real World Vaccine Effectiveness"...

Israeli data: How can efficacy vs. severe disease be strong when 60% of hospitalized are vaccinated?
A surge involving the rapidly-transmitting Delta variant in heavily vaccinated countries has led to much hand-wringing that the vaccines...

Israeli study suggests vaccine efficacy vs. infection decreases over time -- should we be worried?
A couple weeks ago, reports in Israel came out suggesting that Pfizer vaccine efficacy waned over time, sparking discussion of the...

NEJM paper demonstrates mRNA vaccines do NOT increase miscarriage rate.
There are numerous claims circulating on social media suggesting that the mRNA vaccines are dangerous to reproductive health and...

Overwhelming evidence now that previously infected have robust immune protection against reinfection
Key points of this article: An article was published in Israel demonstrating those previously infected with PCR confirmed SARS-CoV-2...

New paper suggests previously infected individuals get full benefit after 1st vaccine dose
A research team at University of Pennsylvania led by my immunologist colleague John Wherry just posted a paper on medRXiv looking at the...

UK study of health care workers provides evidence Pfizer/BioNTech vaccine protects against infection
A preprint was posted today on the Lancet site present results of a study investigating efficacy of Pfizer/BioNTech vaccine in health...

New data out of Israel suggests protection vs. transmission may start 2 weeks after Pfizer 1st dose
The rapid vaccination of the population of Israel with the Pfizer/BioNTech vaccine coupled with its centralized universal healthcare...

Why it is all but certain the SARS-CoV-2 vaccines are protecting against infection and transmission
Do the SARS-CoV-2 vaccines protect against infection and prevent transmission of the virus, or do they simply reduce symptoms of...

Early evidence from Israel suggests that the Pfizer vaccines are working
A group of researchers in Israel have put together a preliminary report tracking cases and hospitalizations since their nationwide...

Phase 3 trial for Russian vaccine Sputnik V published in The Lancet shows positive results
With all of the talk of the Moderna, Pfizer/BioNTech and AstraZeneca/Oxford vaccines, and recent reports of preliminary data from Novavax...

Watch Israel if you want to see early validation of efficacy and safety of SARS-CoV-2 vaccines
The phase 3 studies for Moderna and Pfizer/BioNTech SARS-CoV-2 vaccines yielded outstanding results -->94% efficacy in preventing...

Newborns are born with SARS-CoV-2 antibodies transferred in utero from their mothers
A University of Pennsylvania-Children's Hospital of Philadelphia research team with which I collaborate just published a paper in JAMA...

How alarmed should we be about this new UK variant? Evaluation of the quantitative evidence.
Given this article is somewhat long and involved, I first summarize its key points: A new SARS-CoV-2 variant has emerged and taken over...

New Nature Communications paper suggests robust neutralizing antibodies after COVID-19 recovery
A paper just published in Nature Communications yesterday measured neutralizing antibody levels in 195 individuals with PCR confirmed...

Full vaccine results in, Pfizer/BioNTech stellar, but AstraZeneca/Oxford mixed & require more study
Today we received full data from both the Pfizer/BioNTech Phase 3 vaccine study and the Astrazeneca/Oxford vaccine trials that were...

GREAT News about SARS-CoV-2 Vaccine from Pfizer/BioNtech! Some statistical perspective.
Pfizer has a press release on an interim analysis from their SARS-CoV-2 vaccine trial. Here is a link to an NPR article on the release. ...

Published paper shows nearly 95% still had SARS-CoV-2 antibodies after 6 months.
This study, just published in Clinical Infectious Diseases on Wednesday, presents antibody test results for >2500 healthcare workers and...



























